Skip to main content

Published locations for Dual kinase inhibitor performs well in its first safety, efficacy study for atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dual kinase inhibitor performs well in its first safety, efficacy study for atopic dermatitis

User login

  • Reset your password
  • /content/dual-kinase-inhibitor-performs-well-its-first-safety-efficacy-study-atopic-dermatitis
  • /edermatologynews/article/159374/atopic-dermatitis/dual-kinase-inhibitor-performs-well-its-first
  • /familypracticenews/article/159374/atopic-dermatitis/dual-kinase-inhibitor-performs-well-its-first
  • /internalmedicinenews/article/159374/atopic-dermatitis/dual-kinase-inhibitor-performs-well-its-first
  • /internalmedicine/article/159374/atopic-dermatitis/dual-kinase-inhibitor-performs-well-its-first
  • /dermatology/article/159374/atopic-dermatitis/dual-kinase-inhibitor-performs-well-its-first-safety
  • /familymedicine/article/159374/atopic-dermatitis/dual-kinase-inhibitor-performs-well-its-first-safety